| |
Discovery of new coumarin substituted quinazolines as potential bioactive agents
- 作者:Amit B. Patel ; Rinku M. Raval
- 关键词:Quinazoline ; Coumarin ; Benzothiazole ; Antimicrobial ; Antimycobacterial activity
- 刊名:Research on Chemical Intermediates
- 出版年:2016
- 出版时间:March 2016
- 年:2016
- 卷:42
- 期:3
- 页码:2163-2175
- 全文大小:425 KB
- 参考文献:1.U. Schlipkoter, A. Flahault, Public Health Rev. 32, 90–119 (2010)
2.J. Davies, D. Davies, Microbiol. Mol. Biol. Rev. 74, 417–433 (2010)CrossRef 3.H.-F. Ji, X.-J. Li, H.-Y. Zhang, EMBO Rep. 10, 194–200 (2009)CrossRef 4.C. Ryu, Y.H. Kim, H.A. Im, J.Y. Kim, J.H. Yoon, A. Kim, Bioorg. Med. Chem. Lett. 22, 500–503 (2012)CrossRef 5.A.B. Patel, K.H. Chikhalia, P. Kumari, Res. Chem. Intermed. 41, 2665–2674 (2015)CrossRef 6.S. Yan, Y. Dong, Q. Peng, Y. Fan, J. Zhang, J. Lin, RSC Adv. 3, 5563–5569 (2013) 7.N.M. Raghavendra, P. Thampi, P.M. Gurubasavarajaswamy, D. Sriram, Arch. Pharm. 340, 635–641 (2007)CrossRef 8.D. Li, P. Zhan, H. Liu, C. Pannecouque, J. Balzarini, E. De Clercq, X. Liu, Bioorg. Med. Chem. 21, 2128–2134 (2013)CrossRef 9.S.S. Ibrahim, A.M. Abdel-Halim, Y. Gabr, S. El–Edfawy, R.M. Abdel-Rahman, J. Chem. Res. Synop. 5, 154–155 (1997)CrossRef 10.U. Kabra, C. Chopde, S. Wadodkar, J. Heterocycl. Chem. 48, 1351–1355 (2011)CrossRef 11.A.B. Patel, K.H. Chikhalia, P. Kumari, Med. Chem. Res. 23, 2338–2346 (2014)CrossRef 12.S.M. Mosaad, K.I. Mohammed, M.A. Ahmed, S.G. Abdel-Hamide, J. Biol. Sci. 4, 504–509 (2004)CrossRef 13.S. Kumar, N. Shakya, S. Gupta, J. Sarkar, D.P. Sahu, Bioorg. Med. Chem. Lett. 19, 2542–2545 (2009)CrossRef 14.L. Zhu, J. Jin, C. Liu, C. Zhang, Y. Sun, Y. Guo, D. Fu, X. Chen, B. Xu, Bioorg. Med. Chem. 19, 2797–2807 (2011)CrossRef 15.R.A. Smits, I.J. de Esch, O.P. Zuiderveld, J. Broeker, K. Sansuk, E. Guaita, G. Coruzzi, M. Adami, E. Haaksma, R. Leurs, J. Med. Chem. 51, 7855–7865 (2008)CrossRef 16.K. Kanuma, K. Omodera, M. Nishiguchi, T. Funakoshi, S. Chaki, Y. Nagase, I. Iida, J. Yamaguchi, G. Semple, T. Tran, Y. Sekiguchi, Bioorg. Med. Chem. 14, 3307–3319 (2006)CrossRef 17.V. Ehmke, J.E. Quinsaat, P. Rivera-Fuentes, C. Heindl, C. Freymond, M. Rottmann, R. Brun, T. Schirmeister, F. Diederich, Org. Biomol. Chem. 10, 5764–5768 (2012)CrossRef 18.A.B. Patel, K.H. Chikhalia, P. Kumari, Res. Chem. Intermed. 41, 4439–4455 (2015) 19.T. Akhtar, S. Hameed, N.A. Al–masoudi, R. Loddo, Colla PL. Acta Pharm. 58, 135–149 (2008) 20.S.H. Gillespie, Medical Microbiology-Illustrated (Butterworth Heinemann Ltd., Oxford, 1994), p. 234 21.P.M. Hawkey, D.A. Lewis, Medical Bacteriology—a Practical Approach (Oxford University Press, Oxford, 1994), p. 181 22.P. Anargyros, D.S. Astill, I.S. Lim, J. Clin. Microbiol. 28, 1288–1291 (1990) 23.A.B. Patel, K.H. Chikhalia, P. Kumari, Eur. J. Med. Chem. 79, 57–65 (2014)CrossRef
- 作者单位:Amit B. Patel (1)
Rinku M. Raval (2)
1. Department of Chemistry, Government College Daman, Daman, 396210, UT, India 2. Department of Chemistry, HVHP Institute of PG Studies and Research, KSV, Kadi, 382715, India
- 刊物类别:Chemistry and Materials Science
- 刊物主题:Chemistry
Catalysis Physical Chemistry Inorganic Chemistry
- 出版者:Springer Netherlands
- ISSN:1568-5675
文摘
In view of the biological importance of some important pharmacophores such as quinazoline, coumarin, and benzothiazole, we frame these moieties in a single molecular scaffold to be screened in vitro for their antimicrobial activity. The newly synthesized analogs have been examined for their in vitro biological efficacy against two Gram-positive bacteria, three Gram-negative bacteria, two fungi, and for antimycobacterial activity against M. tuberculosis H37Rv. The bioassay results revealed that the majority of final analogs exhibited potential bio efficacies with the remarkable level of MICs comparable to control drugs. The new synthesized compounds were characterized by FT-IR, 1H NMR, 13C NMR, and MS analysis.
| |
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.
| |